Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 6Duodenal Neoplasms 4Pancreatitis, Chronic 2Biliary Tract Neoplasms 2Pancreatic Fistula 1Neoplasms 1Cholangiocarcinoma 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 92Cisplatin 70Oxaliplatin 37Capecitabine 37durvalumab 29Fluorouracil 26pembrolizumab 24Leucovorin 22S 1 (combination) 18Nivolumab 13Irinotecan 13Bevacizumab 13lenvatinib 12tremelimumab 10apatinib 8Trastuzumab 7Injections 7Albumin-Bound Paclitaxel 7130-nm albumin-bound paclitaxel 7Paclitaxel 6Immune Checkpoint Inhibitors 6Docetaxel 6titanium silicide 5surufatinib 5envafolimab 5camrelizumab 5atezolizumab 5Folfox protocol 5Drug Therapy 5Carboplatin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Biliary Tract Neoplasms × Pancreaticojejunostomy × Clear all
NCT00359320 2025-05-02

A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy

Thomas Jefferson University

Phase NA Terminated
54 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Duodenal Neoplasms, Pancreatic Neoplasms, Pancreatitis, Chronic

NCT01731821 2014-12-04

Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy

Fudan University

Phase 3 Completed
308 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Duodenal Neoplasms, Pancreatic Neoplasms, Pancreatitis, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡